230 studies found for:    "Adrenal Gland Diseases" [DISEASE]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening
Conditions: Adrenal Gland Diseases;   Adrenal Gland Neoplasms
Intervention: Drug: I-131 Iodocholesterol
2 Completed Lipid-poor Adrenal Masses: Evaluation With Chemical Shift MRI
Condition: Adrenal Gland Disease
Intervention: Procedure: MRI
3 Recruiting Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic Adrenalectomy
Condition: Adrenal Disease
Interventions: Procedure: PRA;   Procedure: LA
4 Completed Study of Cushing's Syndrome Not Related to ACTH Production
Conditions: Cushing's Syndrome;   Healthy
Intervention:
5 Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency
Condition: Addison's Disease
Intervention: Drug: dehydroepiandrosterone
6 Not yet recruiting Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492
Conditions: Adrenocortical Adenoma;   Sarcoma, Endometrial Stromal
Interventions: Procedure: MRI;   Procedure: Dexamethasone Supression Test;   Procedure: Sonogram;   Procedure: Biopsy;   Drug: BGG492
7 Unknown  The Significance of Defensin Alpha 4 in the Pathophysiology of the Adrenal Insufficiency in Inflammatory Lung Diseases
Conditions: Adrenal Insufficiency;   Inflammatory Lung Diseases
Intervention:
8 Completed Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism
Condition: Primary Hyperaldosteronism
Intervention: Drug: LCI699
9 Recruiting Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Children
Conditions: Autoimmune Disease;   Congenital Adrenal Hyperplasia;   Healthy;   Mental Disorder Diagnosed in Childhood;   Neurologic Manifestations
Intervention:
10 Recruiting Difference in GC-induced Adrenal Insufficiency in RA Related to Polymorphisms in the Glucocorticoid Receptor Gene
Condition: Rheumatoid Arthritis
Intervention: Other: No intervention
11 Terminated Adrenal Insufficiency in Septic Shock
Conditions: Septic Shock;   Acute Adrenal Insufficiency
Intervention: Drug: Corticosteroid
12 Recruiting Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism
Condition: Mild Hypercortisolism
Intervention: Drug: Mifepristone
13 Completed A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of Antioxidants
Condition: Adrenomyeloneuropathy
Interventions: Drug: N-acetylcysteine;   Drug: lipoic acid;   Drug: vitamin E
14 Completed The Effect of Bezafibrate on the Level of Very Long Chain Fatty Acids (VLCFA) in X-linked Adrenoleukodystrophy (X-ALD)
Conditions: X-linked Adrenoleukodystrophy;   Adrenomyeloneuropathy
Intervention: Drug: Bezafibrate
15 Completed Qualitative Research on Women With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention: Other: Interview
16 Completed Test Predicting Adrenal Insufficiency in Volunteers Under Prednisone Treatment
Condition: Adrenal Gland Hypofunction
Interventions: Procedure: adrenal insufficiency testing;   Drug: prednisone
17 Withdrawn Safety and Pharmacodynamic Study of Sobetirome in X-Linked Adrenoleukodystrophy (X-ALD)
Conditions: X-Linked Adrenoleukodystrophy;   Adrenomyeloneuropathy
Intervention: Drug: Sobetirome
18 Terminated
Has Results
IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery
Conditions: Recurrent Adrenocortical Carcinoma;   Stage III Adrenocortical Carcinoma;   Stage IV Adrenocortical Carcinoma
Interventions: Biological: IMC-A12;   Drug: mitotane
19 Completed Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH
Conditions: Endocrine Disease;   Adrenal Insufficiency;   Congenital Adrenal Hyperplasia
Intervention: Drug: Hydrocortisone Modified Release Capsules
20 Recruiting Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: LCI699

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years